Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Infect Chemother ; 25(8): 643-645, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31053536

ABSTRACT

Serological surveillance of pertussis antibodies was performed in 118 children aged 1-12 years. The positivity of pertussis toxin (PT) antibodies was low at 4-6 years and significantly higher at 8-9 years, compared with those at 6 years. Fimbriae 2 (Fim2) antibody showed similar response to the PT antibody. Higher antibody titers against Fim3 were observed among subjects ≥5 years and highest at 8 years. Data demonstrated that the vaccine-induced antibodies decayed by 4-5 years and subclinical pertussis infection was suspected thereafter, suggesting the need for additional dose at around 4-5 years.


Subject(s)
Bordetella pertussis/immunology , Vaccines/immunology , Whooping Cough/immunology , Antibodies, Bacterial/immunology , Antigens, Bacterial/immunology , Child , Child, Preschool , Female , Fimbriae Proteins/immunology , Fimbriae, Bacterial/immunology , Humans , Infant , Male , Pertussis Toxin/immunology , Vaccination/methods , Virulence Factors, Bordetella/immunology
2.
J Infect Chemother ; 21(9): 639-46, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26134278

ABSTRACT

Isolation of Bordetella pertussis and detection of the pertussis genome are not always successful because of low bacterial loads in adult patients with pertussis. Antibodies against pertussis toxin (PT) are measured but have low sensitivity in vaccinated subjects. There is no reliable diagnostic method at present. In this study, a fluorescent-EIA against several pertussis antigens and genome detection were investigated to establish clinical laboratory diagnostic methods for pertussis. The study was conducted in an outpatient clinic between September 2007 and 2013. Subjects consisted of 209 patients including adults suspected of pertussis and 35 staff members of the clinic. Loop-mediated isothermal amplification (LAMP) was performed to detect the pertussis genome in 5' UTR of the pertussis toxin (PT) gene. The catalytic region of the adenylate cyclase toxin (catACT), C-terminal of filamentous hemagglutinin (cFHA), and type 3 fimbria (Fim3) were selected, which are not pertussis vaccine component. Conventional PT and FHA antibodies were examined together with type 2 fimbria (Fim2) antibodies, and these are vaccine antigens. Pertussis DNA was detected in 23 (11%) out of 209. Detection sensitivity was high in young infants. Antibodies against Fim3 showed a higher positive rate in all age groups. Staff members at the pediatric outpatient clinic showed serological booster responses in Fim2 and Fim3 antibodies more sensitively than those in PT antibodies during outbreaks. LAMP was useful for detecting the pertussis genome in young infants, whereas a serological assay for fluorescent-EIA against Fim2 and Fim3 was preferable for adolescents and adults.


Subject(s)
Antibodies, Bacterial/blood , Antigens, Bacterial/immunology , Bordetella pertussis/immunology , Fimbriae Proteins/immunology , Virulence Factors, Bordetella/immunology , Whooping Cough/diagnosis , Whooping Cough/immunology , 5' Untranslated Regions , Adenylate Cyclase Toxin/immunology , Adhesins, Bacterial/immunology , Adolescent , Adult , Ambulatory Care Facilities , Bordetella pertussis/genetics , Catalytic Domain/immunology , Child , Child, Preschool , DNA, Bacterial/blood , Enzyme-Linked Immunosorbent Assay , Fimbriae, Bacterial/immunology , Fluorescence , Health Personnel , Humans , Infant , Middle Aged , Nucleic Acid Amplification Techniques , Pertussis Toxin/genetics , Pertussis Toxin/immunology , Whooping Cough/blood , Young Adult
3.
J Clin Microbiol ; 46(1): 56-61, 2008 Jan.
Article in English | MEDLINE | ID: mdl-17989200

ABSTRACT

The antigenic cross-reactive characteristics of herpes B virus and herpes simplex virus (HSV) type 1 (HSV-1) and HSV-2 are responsible for false-positive diagnoses by serological assays in humans and macaques. In the present study, we developed a fluorometric indirect enzyme-linked immunosorbent assay (ELISA) with recombinant herpes B virus glycoprotein D (gD) and HSV-1 and HSV-2 gG (gG-1 and gG-2, respectively) to discriminate between the three primate herpesvirus infections. The secreted form of gD, gDdTM, was used to detect antibody to herpes B virus gD. Sera positive for herpes B virus, HSV-1, and HSV-2 showed specific reactions to gD, gG-1, and gG-2, respectively. Sera collected from humans and rhesus macaques were investigated for the presence of antibodies to the recombinant proteins of the three herpesviruses. The results suggested that the approach is able to discriminate between herpes B virus and HSV infections. The ELISA was also found to be able to detect infections with multiple primate herpesviruses and may have the potential to identify a subsequent infection in individuals that have already been infected with another herpesvirus. In addition, we found evidence of a greater cross-reactivity of herpes B virus with HSV-1 than with HSV-2. It is suggested that the ELISA with the recombinant antigens is useful not only for the serodiagnosis of primate herpesvirus infections but also for elucidation of the seroprevalence of herpesviruses in humans and primates.


Subject(s)
Antibodies, Viral/blood , Enzyme-Linked Immunosorbent Assay/methods , Herpesviridae Infections/diagnosis , Herpesvirus 1, Cercopithecine/immunology , Herpesvirus 1, Human/immunology , Herpesvirus 2, Human/immunology , Animals , Antigens, Viral/genetics , Cross Reactions , Herpesviridae Infections/immunology , Humans , Macaca mulatta , Recombinant Proteins/genetics , Viral Envelope Proteins
SELECTION OF CITATIONS
SEARCH DETAIL
...